<DOC>
<DOCNO>EP-0612741</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Cyclic derivatives, medicaments containing them and process for their preparation
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D41700	C07D40104	A61P900	C07D40304	A61K31395	C07D47104	A61P3500	C07D40300	A61P1100	A61P4300	A61K31395	A61P4300	C07D40314	C07D41704	A61P900	A61P702	A61P1100	A61K3147	A61P910	A61P3500	C07F900	A61K3155	A61P2900	A61P300	C07F96558	A61K3155	A61K31472	C07D47100	A61K3147	A61K314725	C07D48700	C07D40302	C07D40100	A61P700	C07D48704	A61P2900	A61P308	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	A61P	C07D	A61K	C07D	A61P	C07D	A61P	A61P	A61K	A61P	C07D	C07D	A61P	A61P	A61P	A61K	A61P	A61P	C07F	A61K	A61P	A61P	C07F	A61K	A61K	C07D	A61K	A61K	C07D	C07D	C07D	A61P	C07D	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D417	C07D401	A61P9	C07D403	A61K31	C07D471	A61P35	C07D403	A61P11	A61P43	A61K31	A61P43	C07D403	C07D417	A61P9	A61P7	A61P11	A61K31	A61P9	A61P35	C07F9	A61K31	A61P29	A61P3	C07F9	A61K31	A61K31	C07D471	A61K31	A61K31	C07D487	C07D403	C07D401	A61P7	C07D487	A61P29	A61P3	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Azobicyclic compounds which are substituted by a cyclic urea radical, or their derivatives, such as e.g. the compound 
<
IMAGE
>
 have cell aggregation-inhibiting actions and can be employed for the preparation of e.g. anti-inflammatory or anti-tumour and anti-thrombotic medicaments.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Cyclic derivatives of general formula,


wherein

X denotes a carbimino group substituted at the nitrogen
atom by a cyano group, or a carbonyl, or a sulphonyl

group,
Y denotes a -CH
2
CH
2
-, -CH
2
CH
2
CH
2
-, -CH=CH-, -CH
2
CO- or
-COCH
2
- group which is optionally substituted by R
c
 or by
R
c
 and R
d
,
or a -CO-NH-, -NH-CO-, -CH=N- or -N=CH- group optionally
substituted by R
c
 or R
d
;
one of the groups R
a
 to R
d
, denotes an A-B group wherein
A is a group of one of the formulae


or


wherein the benzo moiety of the above-mentioned groups
may each be sub
stituted by a fluorine, chlorine or
bromine atom, or by an alkyl, cyano, trifluoromethyl,

hydroxy or alkoxy group, or one to three methine groups
may each be replaced a nitrogen atom,
G
1
 represents a bond or a methylene group which may be
mono or disubstituted by an alkyl group, wherein the

substituents may be identical or different,
G
2
 denotes a bond or a methylene group substituted by R
7

and R
8
,
G
3
 denotes a methylene group substituted by R
9
 and R
10
,
G
4
 denotes a bond,
G
5
 denotes a nitrogen atom or a methine group optionally
substituted by an alkyl group, 
R
2
 denotes a hydrogen atom or an alkyl group,
R
3
 denotes a hydrogen atom or an alkyl group,
R
4
 denotes a hydrogen atom, a cycloalkyl or
cycloalkylalkyl group each having 3 to 7 carbon atoms in

the cycloalkyl moiety, a C
1-6
-alkyl group, a C
3-6
-alkenyl
group (wherein the alkenyl group may not be linked to

the nitrogen atom via the vinyl moiety), or a
hydroxyalkyl, alkoxyalkyl, carboxyalkyl,

alkoxycarbonylalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl,
N,N-dialkylaminocarbonylalkyl,

arylalkyl, alkoxycarbonyl, arylmethyloxycarbonyl,
formyl, acetyl, trifluoroacetyl, or R
11
CO-O-(R
12
CR
13
) -O-CO
group, wherein
R
11
 denotes an alkyl group,
R
12
 denotes a hydrogen atom or an alkyl group, and
R
13
 denotes a hydrogen atom,
or R
4
 together with R
3
 may denote a straight chain
alkylene group having 2 or 3 carbon atoms,
R
5
 denotes a hydrogen atom or an alkyl group, or, if G
1

denotes a bond, R
4
 together with R
5
 may denote another
bond,
R
6
 denotes a hydrogen atom or an alkyl group, or, if G
1

denotes a bond and R
4
 together with R
5
 denotes another
bond, R
6
 may also denote an amino group,
R
7
 denotes a hydrogen atom or an alkyl group,
R
8
 denotes a hydrogen atom or an alkyl group, or R
8

together with R
4
 may denote a straight chain alkylene 
group having 3 or 4 carbon atoms,
R
9
 denotes a hydrogen atom or an alkyl group,
R
10
 denotes a hydrogen atom or an alkyl group, or R
10

together with R
4
 denotes a straight chain alkylene group
having 3 to 4 carbon atoms,
R
14
 denotes a hydrogen atom or an alkyl group,
R
15
 denotes a hydrogen atom or an alkyl group,
R
16
 denotes a hydrogen atom or an alkyl group,
R
17
 denotes a hydrogen atom or an alkyl group or R
16

together with R
17
 may denote another bond,
R
18
 denotes a hydrogen atom or an alkyl group or, if R
16

and R
17
 together denote another bond, R
18
 may denote a
chlorine atom or an amino group,
n represents the number 1 or 2, and
B denotes a bond,
or an alkylene group,
or an arylene group,
or a pyridinylene, pyrimidinylene, pyrazinylene, or
pyridazinylene group, which may optionally be

substituted by one or two alkyl groups,
or a cyclohexylene group optionally substituted by one
or two alkyl groups,
or a piperidinylene group which is optionally 
substituted by one or two alkyl groups, and in which a

methylene group adjacent to a nitrogen atom may be
replaced by a carbonyl group,
the second of the groups R
a
 to R
d
 denotes a group of
formula


F - E - D-

wherein
D denotes an alkylene group,
or an arylene group,
or a pyridinylene, pyrimidinylene, pyrazinylene or
pyridazinylene group, which may optionally be

substituted by one or two alkyl groups,
or an indanylene, naphthylene, 1,2,3,4-tetrahyronaphthylene
or benzosuberanylene group wherein

one of the rings is bound to the group E and the other
ring is bound to the cyclic group of general formula I,
or a C
4-7
-cycloalkylene group optionally substituted by
one or two alkyl groups,
or a C
5-7
-cycloalkylene group which is optionally
substituted by one or two alkyl groups, and in which a


>
CH unit is replaced by a nitrogen atom, whilst moreover
in the above-mentioned 5 to 7 membered rings a methylene

group adjacent to a nitrogen atom may be replaced by a
carbonyl group,
or, if E denotes a cyclic imino group, D may also denote
an alkylenecarbonyl group, wherein the carbonyl group is

bound to the nitrogen atom of the cyclic imino group of 
group E,
or, if E does not represent a bond, D may represent a
bond,
E denotes a bond,
or an alkylene group which may be substituted by a C
1-6
-alkyl
group, by an amino, aryl, alkylamino, dialkylamino

group, or by an HNR
21
 or N-alkyl-NR
21
- group,
R
21
 denotes an alkylcarbonyl or alkylsulphonyl group each
having 1 to 6 carbon atoms in the alkyl moiety, an

alkyloxycarbonyl group having a total of 2 to 5 carbon
atoms, a cycloalkylcarbonyl or cycloalkylsulphonyl group

each having 5 to 7 carbon atoms in the cycloalkyl
moiety, or an arylalkylcarbonyl, arylalkylsulphonyl,

arylalkoxycarbonyl, arylcarbonyl or arylsulphonyl group,
or a C
2-4
 alkenylene group,
or an arylene group,
or a pyridinylene, pyrimidinylene, pyrazinylene or
pyridazinylene group optionally substituted by one or

two alkyl groups.
or a C
5-7
-cycloalkylene group which is optionally
substituted by one or two alkyl groups, and in which a


>
CH unit is replaced by a nitrogen atom linked to a
carbon atom of the group D,
or a cycloalkylene group having 4 to 7 carbon atoms in
the cycloalkylene moiety and which may optionally be

substituted by one or two alkyl groups,
or, if D does not denote a bond, E may also denote an 
alkylene group linked to group D via a group W, wherein

W denotes an oxygen or sulphur atom or a sulphinyl,
sulphonyl, -NR
20
-CO-, or -CO-NR
20
- group, wherein R
20
 may
be a hydrogen atom or an alkyl group and the alkylene

group may additionally be substituted by a C
1-6
- alkyl
group, by an amino, aryl, alkylamino, dialkylamino,

-HNR
21
- or N-alkyl-NR
21
- group, wherein the heteroatom of
the additional substituent is separated from a

heteroatom of the group W by at least two carbon atoms
and R
21
 is as hereinbefore defined, and
F denotes a carbonyl group subsituted by a hydroxy,
alkoxy, arylalkoxy group or by an R
22
O group wherein R
22

denotes a C
5-7
-cycloalkyl group or a cycloalkylalkyl
group having 5 to 7 carbon atoms in the cycloalkyl

moiety,
or a R
23
CO-O-CHR
24
-O-CO- group, phosphono or O-alkylphosphono
group, wherein
R
23
 denotes an alkyl, alkoxy, cycloalkyl or cycloalkyloxy
group each having 5 to 7 carbon atoms in the cycloalkyl

moiety, and
R
24
 denotes a hydrogen atom or an alkyl group,
and the shortest distance between the group F and the
nitrogen atom of group A-B which is furthest from the

group F is at least 11 bonds;
a third of the groups R
a
 to R
d
 denotes a hydrogen atom,
or an alkoxy group, wherein the alkoxy group may not be

bound to a nitrogen atom, or it denotes an alkyl,
trifluoromethyl or aryl group and,
the fourth of the groups R
a
 to R
d
 denotes a hydrogen atom
or an alkyl group;
 
wherein unless otherwise specified


each of the aryl moieties mentioned in the definition of
the above groups is a phenyl group which may be

monosubstituted by R
25
, mono, di or trisubstituted by R
26
,
or monosubstituted by R
25
 and additionally mono or
disubstituted by R
26
, wherein the substituents may be
identical or different and
R
25
 denotes a cyano, aminocarbonyl, alkylaminocarbonyl,
dialkylaminocarbonyl, alkylcarbonyl, alkylsulphenyl,

alkylsulphinyl, alkylsulphonyl or trifluoromethyl group
and
R
26
 denotes an alkyl, hydroxy or alkoxy group or a
fluorine, chlorine or bromine atom, and if two R
26
 groups
are bound to adjacent carbon atoms they may also

represent a straight chain C
3-4
-alkylene group, a 1,3-butadien-1,4-diylene
group or a methylenedioxy group,
and each of the arylene moieties mentioned in the
definition of the above-mentioned groups is a phenylene

group which may be monosubstituted by R
25
, mono or
disubstituted by R
26
, or monosubstituted by R
25
 and
additionally monosubstituted by R
26
, wherein the
substituents may be identical or different and are

defined as hereinbefore,
and unless otherwise specified, the above-mentioned
alkyl, alkylene and alkoxy moieties may each contain 1

to 4 carbon atoms, and each carbon atom in the above
mentioned alkylene and cycloalkylene moieties is linked

to one heteroatom at most
and the tautomers, stereoisomers and salts thereof.
Cyclic derivatives of general formula I according 
to claim 1, wherein:


X denotes a carbonyl or sulphonyl group;
Y represents a -CH
2
CH
2
-, -CH
2
CH
2
CH
2
-, -CH=CH-, CH
2
CO- or
-COCH
2
- group and which may optionally be substituted by
1 or 2 methyl groups,
or a -CO-NH-, -CH=N or -N=CH- group optionally
substituted by R
c
;
one of the groups R
a
 to R
c
 denotes an A-B group wherein
A denotes a group of one of the formulae


or


wherein in the benzo moiety of the above-mentioned
groups, one to two methine groups may each be replaced 

by a nitrogen atom,
G
1
 represents a bond or a methylene group
G
2
 denotes a bond,
G
3
 denotes a methylene group,
G
4
 denotes a bond,
G
5
 denotes a nitrogen atom or a methine group,
R
2
 denotes a hydrogen atom,
R
3
 denotes a hydrogen atom,
R
4
 denotes a hydrogen atom, a cyclopropyl or
cyclopropylmethyl group, a C
1-6
-alkyl group, or an allyl,
hydroxyalkyl, carboxyalkyl, alkoxycarbonylalkyl or

benzyl group,
R
5
 denotes a hydrogen atom,
R
6
 denotes a hydrogen atom,
R
14
 denotes a hydrogen atom or an alkyl group,
R
15
 denotes a hydrogen atom or an alkyl group,
R
16
 denotes a hydrogen atom or an alkyl group,
R
17
 denotes a hydrogen atom or, R
16
 together with R
17

denotes another bond,
R
18
 denotes a hydrogen atom, or, if R
16
 and R
17
 together
denote another bond, R
18
 may also denote an amino group, 
n represents the number 1 or 2, and
B denotes a bond or a phenylene group,
a second of the groups R
a
 to R
c
 denotes a group of
formula


F - E - D-

wherein
D denotes an alkylene group,
or a phenylene group,
or a cyclohexylene group,
or a piperidinylene group, wherein the ring nitrogen
atom is linked to the straight chain alkylene group of

the group E, which may be substituted, or
a bond,
E denotes a straight chain alkylene group which may be
substituted by an alkyl or phenyl group,
or a C
2-4
-alkenylene group,
or a phenylene group,
or, if D does not denote a bond, E may denote a straight
chain O-alkylene group linked to group D via the oxygen

atom, and
F denotes a carbonyl group subsituted by a hydroxy or
alkoxy group, 
and the shortest distance between the group F and the
nitrogen atom of group A-B which is furthest from the

group F is at least 11 bonds; and
a third of the groups R
a
 to R
c
 denotes a hydrogen atom,
an alkoxy group (wherein the alkoxy group cannot be

bound to a nitrogen atom), or an alkyl or phenyl group,
and unless otherwise specified, the above-mentioned
alkyl, alkylene or alkoxy moieties may each contain 1 to

4 carbon atoms, and each carbon atom in the above
mentioned alkylene and cycloalkylene moieties is linked

to one heteroatom at most;
and the tautomers, the stereoisomers and the salts
thereof.
Cyclic derivatives of general formula I according
to claim 1, wherein:


X denotes a carbonyl group,
Y denotes a -CH
2
CH
2
-, -CH
2
CH
2
CH
2
-, -CH=CH-, -CH
2
CO- or
-COCH
2
- group,
or a -N=CH- group optionally substituted by a methyl
group,
the group R
a
 denotes an A-B group wherein
A is a group of one of the formulae


or


wherein in the benzo moiety of the above-mentioned
groups 1 or 2 methine groups may each be replaced by a

nitrogen atom,
G
1
 denotes a bond or a methylene group,
G
2
 denotes a bond,
G
3
 denotes a methylene group,
G
4
 denotes a bond,
G
5
 denotes a methine group,
R
2
 denotes a hydrogen atom,
R
3
 denotes a hydrogen atom,
R
4
 denotes a hydrogen atom, an alkyl group having 1 to 4 
carbon atoms, or an allyl or benzyl group,
R
5
 denotes a hydrogen atom,
R
6
 denotes a hydrogen atom,
R
14
 denotes a hydrogen atom or a methyl group,
R
15
 denotes a hydrogen atom,
R
16
 together with R
17
 denotes a bond,
R
18
 denotes a hydrogen atom or an amino group, and
n represents the number 1
B denotes a bond,
the group R
b
 denotes a group of formula

F - E - D -

wherein
D denotes a -CH
2
CH
2
- group,
or a 1,4-phenylene group,
or a 1,4-cyclohexylene group,
E denotes a -CH
2
CH
2
- group, a -CH=CH-, 1,4-phenylene or
-O-CH
2
- group substituted by a methyl group, wherein the
oxygen atom of the -O-CH
2
- group is linked to the group
D, and
F denotes a carbonyl group substituted by a hydroxy or
alkoxy group having 1 to 4 carbon atoms, 
and the shortest distance between the group F and the
nitrogen atom of group A-B which is furthest from the

group F is at least 11 bonds;
and the tautomers, stereoisomers and salts thereof.
The following compounds of general formula I
according to claim 1:


(a) 1-[4-[2-(methoxycarbonyl)ethyl]phenyl]
-3-(1,2,3,4-tetrahydroisoquinolin-6-yl)-imidazolidin-2-one,
(b) 1-[4-(2-carboxyethyl)phenyl]-3-(1,2,3,4-tetrahydroisoquinolin-6-yl)-imidazolidin-2-one,
(c) 1-[4-(2-carboxyethyl)phenyl]-3-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-imidazolidin-2-one,
(d) 1-[4-[2-(isobutyloxycarbonyl)ethyl]phenyl]
-3-(1,2,3,4-tetrahydroisoquinolin-6-yl)-imidazolidin-2-one,
(e) 1-[4-(2-carboxyethyl)phenyl]-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(f) 1-[4-[2-(methoxycarbonyl)ethyl]phenyl]
-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)
-imidazolidin-2-one,
(g) 1-[4-[2-lisopropyloxycarbonyl)ethyllphenyl]-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(h) 1-[4-(2-carboxyethyl)phenyl]-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)

-imidazolidin-2-one, 
(i) 4-[4-[2-(carboxyethyl)phenyl]-5-methyl-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-4H-1,2,4-triazol-3-one,
(j) 1-[trans-4-(2-carboxyethyl)cyclohexyl]-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(k) 1-[4-[2-(methoxycarbonyl)ethyl]phenyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(l) 1-[4-12-(ethoxycarbonyl)ethyl]phenyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(m) 1-[4-[2-(isopropyloxycarbonyl)ethyl]phenyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(n) 1-[trans-4-(2-carboxyethyl)cyclohexyl]-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(o) 1-[trans-4-[2-(isopropyloxycarbonyl)ethyl]cyclo-hexyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(p) 1-[trans-4-[2-(ethoxycarbonyl)ethyl]cyclohexyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(q) 1-[trans-4-[2-(methoxycarbonyl)ethyl]cyclohexyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,
(r) 1-[trans-4-[(carboxymethyl)oxy]cyclohexyl]
-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one, 
(s) 3-[trans-4-(2-carboxyethyl)cyclohexyl]-1-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)--hydantoin

and
(t) 1-[trans-4-(2-carboxyethyl)cyclohexyl]-3-(3-ethyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)--imidazolidin-2-one,

and the tautomers and the salts thereof.
1-[trans-4-(2-carboxyethyl)cyclohexyl]-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one,

the methyl, ethyl and isopropylesters as well as
the salts thereof.
1-[trans-4-(2-carboxyethyl)cyclohexyl]-3-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-imidazolidin-2-one

and the salts thereof.
Physiologically acceptable salts of the compounds
according to at least one of claims 1 to 6 with

inorganic or organic acids or bases.
Pharmaceutical compositions containing a compound
according to at least one of claims 1 to 6 or a

physiologically acceptable salt according to claim 7,
optionally together with one or more inert carriers

and/or diluents.
Use of a compound according to at least one of
claims 1 to 7 for preparing a pharmaceutical composition

which is suitable for combatting or preventing diseases
in which smaller or larger cell-aggregates occur or

cell-matrix interactions are involved. 
Process for preparing a pharmaceutical composition
according to claim 8, characterised in that a compound

according to at least one of claims 1 to 7 is
incorporated in one or more inert carriers and/or

diluents by a non-chemical method.
Process for preparing the cyclic derivatives
according to claims 1 to 7, characterised in that


a) in order to prepare compounds of general formula I
wherein F denotes a carboxyl group: a compound of

general formula


wherein

R
a
, R
b
, X and Y are as defined in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 denotes an F'-E-D
group, wherein
E and D are as defined in claims 1 to 6 and F'
represents a group which can be converted into a

carboxyl group by hydrolysis, treatment with acids,
thermolysis or hydrogenolysis
is converted into a compound of general formula I
wherein F denotes a carboxyl group by hydrolysis

treatment with acids, thermolysis or hydrogenolysis; or
b) in order to prepare compounds of general formula I
wherein R
16
 and R
17
 together denote another bond, G
4

denotes a bond and R
18
 denotes an amino group, a compound
of general formula 



wherein

R
a
, R
b
, X and Y are as defined in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 denotes an A-B
group wherein B is defined as in claims 1 to 6 and A

denotes a group of the formula


wherein the benzo moiety, R
15
 and G
5
 are defined as in
claims 1 to 6, and
Z
2
 denotes a nucleophilic leaving group,
is reacted with a compound of general formula

H - R
27

wherein R
27
 denotes an amino group, or
c) in order to prepare compounds of general formula I
wherein R
16
 and R
17
 together denote another bond, G
4
 
denotes a bond and R
18
 denotes a chlorine atom, a
compound of general formula



wherein

R
a
, R
b
, X and Y are as defined in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 represents an A-B
group wherein B is defined as specified in claims 1 to 6

and A denotes a group of formula


wherein the benzo moiety, R
15
 and G
5
 are defined as
in claims 1 to 6, is reacted in the presence of an

acid halide, or
d) in order to prepare compounds of general
formula I wherein X denotes a cyano-substituted

carbimino group or a carbonyl or sulphonyl group
and Y denotes a straight chain C
2-3
-alkylene group
optionally substituted by R
c
 or R
d
 or by R
c
 and R
d
:
cyclising a compound of general formula 



wherein

R
a
 and R
b
 are defined as in claims 1 to 6,
X' denotes a cyano-substituted carbimino group or a
carbonyl or sulphonyl group,
one of the groups U
1
 or U
2
 denotes a hydrogen atom and
the other group U
1
 or U
2
 denotes a straight chain C
2-3
-alkylene
group optionally substituted by R
c
 or R
d
 or by
R
c
 and R
d
, to which additionally is terminally bound a
nucleophilic leaving group; or
e) in order to prepare compounds of general formula I
wherein X denotes a carbonyl group and Y denotes a

straight chain C
2-3
- alkylene group mentioned in claims 1
to 6, a compound of general formula


R
28
 - NH - T

is reacted with an isocyanate of general formula

O = C = N - R
29

wherein
one of the groups R
28
 or R
29
 has the meanings given for R
a

in claims 1 to 6 and the other group R
28
 or R
29
 has the
meanings given for R
b
 in claims 1 to 6 and T denotes a
group of the formula


-(CH
2
)
m
 - HC(OR
3O
)
2

optionally substituted in the alkylidene moiety by R
c
 or 
R
d
 or by R
c
 and R
d
, wherein

m denotes the number 1 or 2 and
R
30
 denotes a C
1-4
-alkyl group,

and optionally a compound thus obtained is subsequently
hydrogenated, or
f) in order to prepare compounds of general formula I
wherein G
1
 and G2 each represent a bond, G
3
 represents a
methylene group optionally substituted by a C
1-4
-alkyl
group, R
2
, R
4
 and R
5
 each represent a hydrogen atom, and
R
3
 and R
6
 which may be identical or different each
represent a hydrogen atom or a C
1-4
-alkyl group:
hydrogenation of a compound of general formula



wherein

R
a
, R
b
, X and Y are defined as in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 denotes an A-B
group, wherein B is defined as in claims 1 to 6 and A

denotes a group of the formula

 
wherein
the benzo moiety and R
15
 are defined as in claims 1
to 6,
G
5
' denotes a methine group optionally substituted by a
C
1-4
-alkyl group, and
R
18
' denotes a hydrogen atom or a C
1-4
 alkyl group; or
g) in order to prepare compounds of general formula I
wherein F denotes a carbonyl group substituted by a C
1-4
-alkoxy
group, by an arylalkoxy group (having 1 to 4

carbon atoms in the alkoxy moiety and wherein the aryl
moiety is defined as in claims 1 to 6), or by an R
22
O
group, a compound of general formula



wherein

R
a
 R
b
, X and Y are defined as in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 denotes an F"-E-D
group, wherein
E and D are defined as in claims 1 to 6 and
F" denotes a carboxy or alkoxycarbonyl group,
is reacted with an alcohol of general formula


HO - R
31

wherein
R
31
 has the meanings given for R
22
 in claims 1 to 6 or 
denotes a C
1-4
-alkyl group or an arylalkyl group in which
the aryl moiety is defined as in claims 1 to 6 and the

alkyl moiety may contain 1 to 4 carbon atoms, or
h) in order to prepare compounds of general formula I
wherein R
4
 represents one of the optionally substituted
alkyl, alkenyl, cycloalkyl, cycloalkylalkyl or aralkyl

groups mentioned in claims 1 to 6 in the definition of
groups R
4
, a compound of general formula


wherein

R
a
, R
b
, X and Y are defined as in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 denotes an A-B
group, wherein
A and B are defined as in claims 1 to 6, with the
proviso that R
4
 represents a hydrogen atom
is reacted with a compound of general formula

Z
3
 - R
32

wherein

R
32
 denotes a C
1-6
-alkyl group, a cycloalkyl or
cycloalkylalkyl group in which the cycloalkyl moiety may

contain 3 to 7 carbon atoms and the alkyl moiety may
contain 1 to 4 carbon atoms, a C
3-6
-alkenyl group, or an
arylalkyl, hydroxyalkyl, alkoxyalkyl, carboxyalkyl,

alkoxycarbonylalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl
or N,N-dialkylaminocarbonyl

group, wherein the aryl moiety and the alkyl moieties
are defined as in claims 1 to 6, and
Z
3
 denotes a nucleophilic leaving group, or 
Z
3
 together with an adjacent hydrogen atom of the group
R
32
 denotes an oxygen atom, optionally in the presence of
a reducing agent; or
i) in order to prepare compounds of general formula I
wherein X represents a carbimino group which is

substituted by a cyano group at the nitrogen atom, or X
denotes a carbonyl or sulphonyl group, a compound of

general formula


is reacted with a compound of general formula


Z
4
 - R
34

wherein

Y is defined as in claims 1 to 6,
X" denotes a carbimino group substituted by a cyano
group at the nitrogen atom, or X" denotes a carbonyl or

sulphonyl group, one of the groups R
33
 or R
34
 has the
meanings given for R
a
 in claims 1 to 6 and the other
group R
33
 or R
34
 has the meanings given for R
b
 in claims 1
to 6 and Z
4
 denotes a nucleophilic leaving group; or
j) in order to prepare compounds of general formula I
wherein R
4
 denotes an alkoxycarbonyl,
arylmethyloxycarbonyl, formyl, acetyl, trifluoroacetyl,

or R
11
CO-O-(R
12
CR
13
)-O-CO- group, wherein R
11
 to R
13
 and the
aryl moiety are defined as in claims 1 to 6 and the

alkoxy moiety may contain 1 to 4 carbon atoms, a
compound of general formula


 
wherein


R
a
, R
b
, X and Y are defined as in claims 1 to 6, with the
proviso that R
4
 denotes a hydrogen atom is reacted with a
compound of general formula


Z
5
 - R
35

wherein
R
35
 represents an alkoxycarbonyl group having a total of
2 to 5 carbon atoms, an arylmethyloxycarbonyl group in

which the aryl moiety is defined as in claims 1 to 6, or
a R
11
CO-O-(R
12
CR
13
) -O-CO, formyl, acetyl, or
trifluoroacetyl group, wherein R
11
 to R
13
 are defined as
in claims 1 to 6, and
Z
5
 denotes a nucleophilic leaving group; or
k) in order to prepare compounds of general formula I
wherein F denotes a carbonyl group which is substituted

by a C
1-4
-alkoxy group, by an arylalkoxy group (in which
the aryl moiety is as defined in claims 1 to 6 and the

alkoxy moiety may contain 1 to 4 carbon atoms), or by an
R
22
O- or R
23
CO-O-CHR
24
O- group, wherein R
22
 to R
24
 are
defined as in claims 1 to 6:

reacting a compound of general formula


wherein

R
a
, R
b
, X and Y are defined as in claims 1 to 6, with the
proviso that one of the groups R
a
 to R
d
 denotes an
F"'-E-D- group wherein
E and D are defined as in claims 1 to 6 and
F"' denotes a carboxyl group
 
with a compound of general formula


Z
6
 - R
36

wherein
R
36
 represents a C
1-4
-alkyl group, an arylalkyl group (in
which the aryl moiety is defined as in claims 1 to 6 and

the alkyl moiety may contain 1 to 4 carbon atoms), or a
R
22
- or R
23
CO-O-CHR
24
 group (wherein R
22
 to R
24
 are defined
as in claims 1 to 6), and
Z
6
 denotes a nucleophilic leaving group; or

l) in order to prepare compounds of general formula I
wherein X denotes a carbonyl group and Y denotes an

ethylene group which is optionally substituted by R
c
 or
R
d
 or by R
c
 and R
d
, and in which a methylene group is
replaced by a carbonyl group: cyclising a compound of

general formula


wherein

R
a
 and R
b
 are defined as in claims 1 to 6,
X" denotes a carbonyl group,
one of the groups U3 or U
4
 denotes a hydrogen atom and
the other group U
3
 or U
4
 denotes an ethylene group which
is optionally substituted by R
c
 or R
d
 or by R
c
 and R
d
, and
in which a methylene group is replaced by a Z
7
-CO group,
wherein Z
7
 denotes a nucleophilic leaving group,
optionally formed in the reaction mixture,

and subsequently, if desired, a compound of general
formula I thus obtained which contains an unsaturated

carbon-carbon bond, is converted by catalytic
hydrogenation into a corresponding saturated compound of

general formula I, and/or
 
if necessary, a protecting group used during the

reactions to protect any reactive groups is cleaved and/
or

a compound of general formula I thus obtained is
resolved into the stereoisomers thereof and/or

a compound of general formula I thus obtained is
converted into the salts thereof, more particularly for

pharmaceutical use into the physiologically acceptable
salts thereof with an inorganic or organic acid or base.
</CLAIMS>
</TEXT>
</DOC>
